Free Guest Resources

Free comprehensive reports for Guest members.

Did you know? You can view every question asked in each report by clicking on the + symbol

2020 How KOLs prefer to engage with MSLs during the COVID-19 pandemic

Are you a professional that regularly interacts with Medical Science Liaisons (MSLs) from industry partners like pharmaceutical companies?

During the COVID-19 pandemic, how valuable have engagements been with MSLs?

How important is it for KOLs to maintain contact with Medical Science Liaisons during the COVID-19 pandemic?

In general, as a result of the COVID-19 pandemic, how frequently do KOLs prefer to communicate with a Medical Science Liaison?

How receptive are KOLs to engaging virtually (Zoom, Skype, Webex, etc.) with MSLs?

Beyond the COVID-19 pandemic, should MSLs continue to utilize virtual technology to engage with you?

Report Results and Infographic

MSL Insights Weekly Show
MSL Interviews Video - Spain
MSL Activities During the COVID-19 Pandemic

Are you currently employed as a Medical Science Liaison (or equivalent title) or do you currently manage MSLs?

What is your current role?

In which country do you work?

How would you classify your company?

How many years of MSL and/or MSL management experience do you have?

What Therapeutic Area best describes your responsibility?

How many MSLs are there on your immediate team (within the same TA, supporting the same product/indication, including yourself, if appropriate)?

How many MSLs do you directly manage (only include MSLs on your team that report directly to you)?

Has all interviewing/hiring for all vacant MSL positions on your team been temporarily halted as a result of COVID-19?

Has COVID-19 specifically reduced INTERVIEWING for vacant MSL positions?

Has COVID-19 specifically reduced HIRING new MSLs for your team?

Are MSLs at your company utilizing virtual meetings to lead ROUNDTABLE discussions with KOLs and other healthcare providers?

Are MSLs at your company utilizing virtual meetings to lead Advisory Boards with KOLs and other healthcare providers?

How receptive are KOLs and/or other healthcare providers to virtual interactions via WebEx or Skype or other virtual platforms?

Does your company allow MSLs to share/project a journal article etc. via virtual meeting platforms such as WebEx, Zoom, etc., if appropriate for the meeting?

What virtual technologies are your organization using for communicating and/or engaging with KOLs and/or other healthcare providers?

Overall, what percentage of KOL engagement or access (phone, virtual, in-person) has been REDUCED as a result of COVID-19?

WHEN you have a virtual engagement with a KOL or other healthcare providers, how long do they typically last?

What tactics have worked for you to obtain virtual engagements with a KOL or other healthcare providers?

As a result of COVID-19 and the evolving business environment, what are you doing to demonstrate value to the company and/or your team?

On average, how many virtual KOL engagements do you have per week, as a result of COVID-19?

As a result of COVID-19, are you getting less time, on average, during a virtual KOL engagement versus your typical in-person meetings?

How have MSLs found additional ways/opportunities to support KOLs and/or other healthcare providers?

Has the MSL team been provided adequate and specific training to effectively conduct virtual KOL engagement meetings and interactions?

As a result of COVID-19, and the need for virtual engagements with a KOL, are there additional training topics that would be beneficial?

Have all or some KPIs and metrics been paused as a result of COVID-19?

Have any new KPIs and metrics been introduced as a result of COVID-19?

zWhat alternative activities and projects are/should MSLs be focusing on as a result of travel restrictions/bans and reduced KOL engagements?

Select the THREE (3) alternative activities / projects you spend the most time on as a result of travel restrictions/bans and reduced KOL engagements?

Do you think there will be any permanent long-term impact or changes to the MSL profession as a result of the COVID-19 pandemic?

What do you think will be the long-term impact or changes to the MSL profession as a result of the COVID-19 pandemic?

As a result of COVID-19, are you worried about your job security?

Has the information you received regarding the impact of COVID-19 on your company, been timely, transparent, and clear?

Global, USA & Spain Results

2019 Most Common MSL Related Acronyms and Terms

Quick reference to 240 of Most Common MSL Related Acronyms and Terms

Global Results

2017 Global MSL Salary & Compensation Survey

Participant Demographics – What is your current role?

Participant Demographics – How many non-people management employment levels are available within the MSL function (or equivalent) at your organization such as Sr. MSL, Level 1 etc.?

Participant Demographics – In which country do you work?

Participant Demographics – How would you classify your company?

Participant Demographics – How many years of MSL and/or MSL management experience do you have?

Participant Demographics – What is your highest academic background?

Participant Demographics – What Therapeutic Area best describes your responsibility? (You may select more than one if appropriate.)

Participant Demographics – What is your gender?

What is your current annual base salary?

Did you negotiate the most recent base salary you were offered (even if it was a merit increase for the same company/role)?

As a result of negotiating, what was the percentage increase you received in your final base salary offer?

If you received a SIGN-ON bonus as part of your new hire compensation, what was the amount of the bonus?

Have you had a base salary increase in the past 12 months? If yes, please select the closest percentage (%) range to your actual salary increase.

If you received a (year-end, quarterly, semi-annual etc.) bonus, what was the total amount paid in the last 12 months?

Please indicate as a percentage of your base salary, the maximum bonus you are eligible for annually.

As part of your compensation package, during the last 12 months, did you receive any company stock or stock options?

Indicate the value of stock options you received during the last 12 months as part of your compensation

Which of the following benefits do you receive as part of your overall compensation?

Which of the following are benefits that you currently DO NOT receive as part of your overall compensation but would like to receive?

As part of your compensation, how many Paid Time Off (holiday or vacation time) days do you receive each year?

USA Results

UK Results

Spain Results

Portugal Results

France Results

Germany Results

Canada Results

Australia Results

India Results

Netherlands Results

Turkey Results

Taiwan Results

Brazil Results

Italy Results

Mexico Results

Global Results